Cellulose / kanker

Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION This invention relates to prevention and treatment of various infectious agents and in particular, relates to inhibitory activity of cellulose sulfate and other sulfated polysaccharides against various infectious agents, including papilloma virus and various vaginitis-causing

Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION This invention relates to prevention and treatment of various infectious agents and in particular, relates to inhibitory activity of cellulose sulfate and other sulfated polysaccharides against various infectious agents, including papilloma virus and various vaginitis-causing

Nutritional composition

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

TECHNICAL FIELD The present invention relates to a nutrient composition (nutritional composition) having lipid metabolism-improving action. The nutrient composition highly effectively contributes to decrease of neutral lipids (triglycerides). The nutrient composition is expected to offer

Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FEDERALLY SPONSORED RESEARCH STATEMENT Not applicable. FIELD OF THE INVENTION The present invention relates to novel compositions for and methods of treating symptoms, syndromes, pathological conditions and disease-associated problems mediated by oxidative stress. These conditions include cancer,

Ondansetron orally disintegrating tablets

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention generally relates to non-effervescent, solid dosage forms adapted for oral administration of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carb- azol-4-one (ondansetron) as an anti-emetic active

Recognins and their chemoreciprocals

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

THE INVENTION This invention is directed to a novel group of compounds, herein termed Recognins. Recognins are made by treating normal or diseased cells or tissues, e.g. tumor cells or artificial cancer cells and separating the desired products. The Recognins may be used to prepare their

Compositions containing micronized tanaproget prepared by wet granulation

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION Micronized tanaproget and compositions containing the same are provided. Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family,

Compositions containing micronized tanaproget prepared by wet granulation

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION Micronized tanaproget and compositions containing the same are provided. Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family,

Micronized tanaproget, compositions, and methods of preparing the same

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen

Micronized tanaproget, compositions, and methods of preparing the same

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen

Micronized tanaproget, compositions, and methods of preparing the same

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen

Micronized tanaproget and compositions containing same

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen

Solid dosage forms of oleyl phosphocholine

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

The present invention relates to solid dosage forms of oleyl phosphocholine (C18:1-PC), or OlPC, for oral administration. Further, the present invention relates to methods for the preparation of the present solid dosage forms and the use thereof as a medicament and especially a medicament for the

Dosage forms having prolonged active ingredient release

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

RELATED APPLICATIONS This is a National Stage of International Application Number PCT/CH02/00486, filed Sep. 4, 2002, which claims priority of EP patent application 01810865.4 filed Sep. 10, 2001. FIELD OF THE INVENTION The invention relates to solid, orally administrable pharmaceutical dosage forms

Extract of Lepidium meyenii roots for pharmaceutical applications

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

The present invention relates to compositions containing particular components that can be obtained from a plant which can have pharmaceutical applications. More particularly, the plant genus is Lepidium. Lepidium meyenii, commonly called maca or Peruvian ginseng, is a perennial plant having a

cellulose/kanker

Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

Nutritional composition

Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance

Ondansetron orally disintegrating tablets

Recognins and their chemoreciprocals

Compositions containing micronized tanaproget prepared by wet granulation

Compositions containing micronized tanaproget prepared by wet granulation

Micronized tanaproget, compositions, and methods of preparing the same

Micronized tanaproget, compositions, and methods of preparing the same

Micronized tanaproget, compositions, and methods of preparing the same

Micronized tanaproget and compositions containing same

Solid dosage forms of oleyl phosphocholine

Dosage forms having prolonged active ingredient release

Extract of Lepidium meyenii roots for pharmaceutical applications

Database tanaman obat terlengkap yang didukung oleh sains